Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: ZRSR2[original query] |
---|
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
Mutational spectrum of adult T-ALL. Oncotarget 2015 Feb 6 (5): 2754-66. Neumann Martin, Vosberg Sebastian, Schlee Cornelia, Heesch Sandra, Schwartz Stefan, Gökbuget Nicola, Hoelzer Dieter, Graf Alexander, Krebs Stefan, Bartram Isabelle, Blum Helmut, Brüggemann Monika, Hecht Jochen, Bohlander Stefan K, Greif Philipp A, Baldus Claudia |
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leukemia research 2016 Oct 49 108-12. Berman Ellin, Jhanwar Suresh, Hedvat Cyrus, Arcila Maria E, Wahab Omar Abdel-, Levine Ross, Maloy Molly, Ma Wanlong, Albitar Mah |
Identification of Novel Oncogenic Mutations in Thyroid Cancer. Journal of the American College of Surgeons 2016 Jan . Pitt Susan C, Hernandez Roland A, Nehs Matthew A, Gawande Atul A, Moore Francis D, Ruan Daniel T, Cho Nancy |
Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia. Blood advances 2018 5 2 (9): 1000-1012. Imi Tatsuya, Katagiri Takamasa, Hosomichi Kazuyoshi, Zaimoku Yoshitaka, Hoang Nguyen Viet, Nakagawa Noriharu, Tajima Atsushi, Yoshizato Tetsuichi, Ogawa Seishi, Nakao Shin |
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib. Blood 2019 10 134 (23): 2107-2111. O'Sullivan Jennifer M, Hamblin Angela, Yap Christina, Fox Sonia, Boucher Rebecca, Panchal Anesh, Alimam Samah, Dreau Helene, Howard Kieran, Ware Pauline, Cross Nicholas C P, McMullin Mary Frances, Harrison Claire N, Mead Adam |
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged?<60 years. Leukemia 2020 May . Eisfeld Ann-Kathrin, Kohlschmidt Jessica, Mims Alice, Nicolet Deedra, Walker Christopher J, Blachly James S, Carroll Andrew J, Papaioannou Dimitrios, Kolitz Jonathan E, Powell Bayard E, Stone Richard M, de la Chapelle Albert, Byrd John C, Mrózek Krzysztof, Bloomfield Clara |
Defining Acute Myeloid Leukemia Ontogeny in Older Patients. Clinical lymphoma, myeloma & leukemia 2019 Nov . Melody Megan, Kuykendall Andrew, Sallman David, Al Ali Najla, Zhang Ling, Talati Chetasi, Padron Eric, Sweet Kendra, Extermann Martine, List Alan, Lancet Jeffrey, Komrokji Ra |
Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Journal of clinical pathology 2020 3 73 (11): 728-736. Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl |
Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico. Oncotarget 2020 12 11 (47): 4411-4420. Jiang Zeju, Sun Xinlai, Wu Zhao, Alhatem Albert, Zheng Ruifang, Liu Dongfang, Wang Yaqun, Kumar Dibyendu, Xia Changqing, You Bei, Wang He, Liu Chen, Jiang Jie-G |
Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia. Blood 2021 6 138 (14): 1249-1257. Tsaknakis Grigorios, Gallì Anna, Papadakis Stavros, Kanellou Peggy, Elena Chiara, Todisco Gabriele, Bono Elisa, Rizzo Ettore, Molteni Elisabetta, Fragiadaki Irene, Mavroudi Irene, Pontikoglou Charalampos, Batas Anastasios, Maxouri Stella, Linardaki Emmanouela, Tavernarakis Nektarios, Malcovati Luca, Papadaki Helen |
Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia. Neoplasma 2021 5 68 (5): 1072-1078. Wu Ming, Guo Zi-Wen, Huang Gui-Nian, Ye Yong-B |
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology. International journal of molecular sciences 2021 Mar 22 (5): . Karantanos Theodoros, Jain Tania, Moliterno Alison R, Jones Richard J, DeZern Amy |
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood advances 2021 Apr 5 (8): 2173-2183. Lachowiez Curtis A, Loghavi Sanam, Furudate Ken, Montalban-Bravo Guillermo, Maiti Abhishek, Kadia Tapan, Daver Naval, Borthakur Gautam, Pemmaraju Naveen, Sasaki Koji, Alvarado Yesid, Yilmaz Musa, Short Nicholas J, Chien Kelly, Ohanian Maro, Pierce Sherry, Patel Keyur P, Jabbour Elias, Ravandi Farhad, Kantarjian Hagop M, Garcia-Manero Guillermo, Takahashi Koichi, Konopleva Marina Y, DiNardo Courtney |
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood advances 2021 3 5 (5): 1540-1551. Renosi Florian, Roggy Anne, Giguelay Ambre, Soret Lou, Viailly Pierre-Julien, Cheok Meyling, Biichle Sabeha, Angelot-Delettre Fanny, Asnafi Vahid, Macintyre Elizabeth, Geffroy Sandrine, Callanan Mary, Petrella Tony, Deconinck Eric, Daguindau Etienne, Harrivel Véronique, Bouyer Sabrina, Salaun Véronique, Saussoy Pascale, Feuillard Jean, Fuseau Pascal, Saas Philippe, Adotévi Olivier, Jardin Fabrice, Ferrand Christophe, Preudhomme Claude, Colinge Jacques, Roumier Christophe, Garnache-Ottou Franci |
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 2021 12 13 (23): . Yin C Cameron, Pemmaraju Naveen, You M James, Li Shaoying, Xu Jie, Wang Wei, Tang Zhenya, Alswailmi Omar, Bhalla Kapil N, Qazilbash Muzaffar H, Konopleva Marina, Khoury Joseph |
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia. European journal of haematology 2021 1 106 (4): 500-507. Jajosky Audrey N, Sadri Navid, Meyerson Howard J, Oduro Kwadwo A, Kelkar Ashwin, Fitzgerald Brynn, Tomlinson Benjamin, Moore Erika M, Beck Rose |
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia. Bone marrow transplantation 2022 Sep . Song Ga-Young, Kim TaeHyung, Ahn Seo-Yeon, Jung Sung-Hoon, Kim Mihee, Yang Deok-Hwan, Lee Je-Jung, Choi Seung Hyun, Kim Mi Yeon, Jung Chul Won, Jang Jun-Ho, Kim Hee Je, Moon Joon Ho, Sohn Sang Kyun, Won Jong-Ho, Park Seong-Kyu, Kim Sung-Hyun, Zhang Zhaolei, Ahn Jae-Sook, Kim Hyeoung-Joon, Kim Dennis Dong Hw |
Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients. American journal of hematology 2022 9 97 (12): 1589-1598. Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm. Frontiers in oncology 2022 7 12 903113. Fei Fei, Liedtke Michaela, Silva Osc |
Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia. Wiener medizinische Wochenschrift (1946) 2022 11 173 (1-2): 21-26. Zack Marie-Therese, Geissler Kla |
Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome. Journal of clinical and experimental hematopathology : JCEH 2023 9 63 (3): 173-176. Pakasticali Nagehan, Mirza Sabbir, Jinming Song, Hussaini Mohamm |
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood 2023 7 . Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas J Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry A Pierce, Kelly Sharon Chien, Koji Sasaki, Tapan M Kadia, Danielle Hammond, Gautam Borthakur, Keyur P Patel, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Courtney D DiNar |
Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia. Molecular biology reports 2023 6 . Wenbo Jia, Xiaodong Guo, Yihong Wei, Jinting Liu, Can Can, Ruiqing Wang, Xinyu Yang, Chunyan Ji, Daoxin |
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes. Blood advances 2023 1 . Wang Yu-Hung, Lin Chien-Chin, Yao Chi-Yuan, Amaral Fabio, Yu Shan-Chi, Kao Chein-Jun, Shih Pin-Tsen, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: